Global Dermatophytic Onychomycosis Market - Asia Pacific is
projected to expand at the highest CAGR by 2015 - 2021
Persistence Market Research
Global Dermatophytic Onychomycosis
Market expected to progress US$ 4,706.3 Mn
by the end of 2021 - Persistence Market
Research
Persistence Market Research
1
Global Dermatophytic Onychomycosis Market - Asia Pacific is
projected to expand at the highest CAGR by 2015 - 2021
Persistence Market Research Released New Market Report “Global Market Study on
Dermatophytic Onychomycosis Therapeutics (DOT): North America Expected to
Account for Maximum Market Share by 2021”.
The global dermatophytic onychomycosis therapeutics market is anticipated to expand at a
healthy CAGR during the forecast period. By product type, the market is segmented into Nail
paint and tablet, which is again sub-divided into prescription (Rx) and over-the-counter (OTC)
sub segments. The nail paint segment is expected to contribute a maximum share to the
global dermatophytic onychomycosis therapeutics market and expand at the fastest CAGR
of 8.3% during the forecast period. By treatment, the market is segmented into topical and
oral therapy. Among these, the topical segment is anticipated to be dominant throughout the
forecast period and projected to account for about 70% share of the total global
dermatophytic onychomycosis market revenue by 2021. By distribution channels, the
market is segmented into hospitals, dermatology and podiatry clinics, independent
pharmacies, mail order pharmacies, and drug stores. Among these, drug stores are
estimated to be largest segment with 47% share of the total global market revenue by 2015
end. The drug stores segment is expected to register the fastest CAGR during the forecast
period. Independent pharmacies are projected to be the second most attractive segment of
the global dermatophytic onychomycosis therapeutics market by 2015 end.
Market growth is primarily driven by factors such as increase in the prevalence of fungal toe
nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across
the globe. Easy application of nail paints is also expected to drive demand for dermatophytic
onychomycosis drugs. However, adverse effects associated with anti-fungal drugs and lack
of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa,
and Latin America are expected to impede growth of the global dermatophytic
onychomycosis therapeutics market.
This report covers global and regional trends along with an analysis of the market potential.
North America is expected to account for over 43% revenue share of the total dermatophytic
onychomycosis therapeutics market by 2015 end i.e. holding the maximum market share.
Persistence Market Research
2
Global Dermatophytic Onychomycosis Market - Asia Pacific is
projected to expand at the highest CAGR by 2015 - 2021
Whereas Europe is projected to grow at a healthy CAGR of 7.3% due to increasing awareness
about fungal nail infections.
Interested in report: Please follow the below links to meet your requirements;
Request for the Report Sample:
http://www.persistencemarketresearch.com/samples/5840
View TOC (table of content), Figures and Tables of the Report:
http://www.persistencemarketresearch.com/toc/5840
Global dermatophytic onychomycosis therapeutics market report begins with an overview of
the global market in terms of value. This section includes detailed analysis of key trends,
drivers and restraints, and opportunities. All of these are factors that impact market growth.
Impact analysis of key growth drivers and restraints based on the weighted average of each
one of these factors in a model-based approach is included in the market report to better
equip clients with crystal clear decision-making insights.
For more info: http://www.persistencemarketresearch.com/contact-us.asp
Key players of the global dermatophytic onychomycosis therapeutics market include
Galderma S.A., Valeant Pharmaceuticals International Inc., Novartis AG, Pfizer Inc., Janssen
Pharmaceuticals, and others. Leading companies in this market collaborate with healthcare
solutions and services providers in order to advance operational efficiencies and provide
improved patient care.
Persistence Market Research
3
Global Dermatophytic Onychomycosis Market - Asia Pacific is
projected to expand at the highest CAGR by 2015 - 2021
Market History:
Dermatophytic onychomycosis is a fungal infection of nail caused by dermatophytes. It
makes the nails look white and opaque, thickened, and brittle. People in the age group of 6065 years with diabetes or disease of the small blood vessels (peripheral vascular disease)
are at increased risk. Dermatophytic onychomycosis therapeutics market consists of drugs
used for a treatment of the disease.
The global dermatophytic onychomycosis therapeutics market was valued at US$ 2,870 Mn
in 2014. North America was the largest market for dermatophytic onychomycosis
therapeutics, accounting for over 43% revenue share of the overall market in 2014, followed
by Europe with around 28% share. North America market is expected to exhibit the highest
CAGR of 9.2% during the forecast period (2015–2021), followed by Europe. Factors such as
increasing per capita healthcare spending, rising aging population, consumers’ disposition
towards maintaining aesthetic appearing nails, and growing product innovation are expected
to support the growth of the dermatophytic onychomycosis therapeutics market during the
forecast period.
The global dermatophytic onychomycosis therapeutics market is projected to be valued at
US$ 3,057.8 Mn by the end of 2015 and is further expected to reach US$ 4,706.3 Mn by the
end of 2021, at a CAGR of 7.5%.
By product, the nail paint segment accounted for about 70% share of overall market value in
2014. By treatment, the oral segment was valued at US$ 861 Mn in 2014 and is expected to
increase at a CAGR of 5.2% during the forecast period to account for US$ 1,221.9 Mn by
2021. By distribution channels, the drug store segment contributed the highest revenue of
US$ 1,343.2 Mn, accounting for approximately 47% market share in 2014. Independent
pharmacies were the second-largest segment by distribution channel, accounting for about
20% revenue share in 2014.
Key players of the global dermatophytic onychomycosis therapeutics market include Valeant
Pharmaceuticals International Inc., Galderma S.A., Novartis AG, Pfizer Inc., Moberg Pharma
AB, Johnson & Johnson Services, Inc., and Anacor Pharmaceuticals, Inc.
Persistence Market Research
4
Global Dermatophytic Onychomycosis Market - Asia Pacific is
projected to expand at the highest CAGR by 2015 - 2021
Persistence Market Research
5
Global Dermatophytic Onychomycosis Market - Asia Pacific is
projected to expand at the highest CAGR by 2015 - 2021
Table of Content
1. Assumptions and Acronyms Used
2. Research Methodology
3. Executive Summary
4. Dermatophytic Onychomycosis Therapeutics Market Overview
4.1. Introduction
4.1.1. Dermatophytic Onychomycosis Therapeutics Market Definition
4.1.2. Dermatophytic Onychomycosis Therapeutics Market Taxonomy
4.1.3. Dermatophytic Onychomycosis Therapeutics Market Parent Overview
4.2. Dermatophytic Onychomycosis Therapeutics Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.2.4. Trends
5. Global Dermatophytic Onychomycosis Therapeutics Market Analysis, By Product
Type
5.1. Introduction
5.1.1. Y-o-Y Growth Comparison, By Product Type
5.1.2. Market Share & Basis Point (BPS) Analysis, By Product Type
5.2. Market Forecast, By Product Type
5.2.1. Tablet
5.2.1.1. Market Size Forecast and Y-o-Y Growth
5.2.1.2. Absolute $ Opportunity
5.2.1.3. Rx. Tablet
5.2.1.3.1. Market Size Forecast and Y-o-Y Growth
5.2.1.3.2. Absolute $ Opportunity
5.2.1.4. OTC Tablet
5.2.1.4.1. Market Size Forecast and Y-o-Y Growth
5.2.1.4.2. Absolute $ Opportunity
Persistence Market Research
6
Global Dermatophytic Onychomycosis Market - Asia Pacific is
projected to expand at the highest CAGR by 2015 - 2021
5.2.2. Nail Paint
5.2.2.1. Market Size Forecast and Y-o-Y Growth
5.2.2.2. Absolute $ Opportunity
5.2.2.3. Rx. Nail Paint
5.2.2.3.1. Market Size Forecast and Y-o-Y Growth
5.2.2.3.2. Absolute $ Opportunity
5.2.2.4. OTC Nail Paint
5.2.2.4.1. Market Size Forecast and Y-o-Y Growth
5.2.2.4.2. Absolute $ Opportunity
5.3. Market Attractiveness Analysis, By Product Type
6. Global Market Analysis, By Treatment Type
6.1. Introduction
6.1.1. Y-o-Y Growth Comparison, By Treatment Type
6.1.2. Market Share & Basis Point (BPS) Analysis, By Treatment Type
6.2. Market Forecast, By Treatment Type
6.2.1. Oral Therapy
6.2.1.1. Market Size Forecast and Y-o-Y Growth
6.2.1.2. Absolute $ Opportunity
6.2.2. Topical Therapy
6.2.2.1. Market Size Forecast and Y-o-Y Growth
6.2.2.2. Absolute $ Opportunity
6.3. Market Attractiveness Analysis, By Treatment Type
6.4. Prominent Trends
7. Global Market Analysis, By Distribution Channels
7.1. Introduction
7.1.1. Y-o-Y Growth Comparison, By Distribution Channels
7.1.2. Market Share & Basis Point (BPS) Analysis, By Distribution Channels
7.2. Market Forecast, By Distribution Channels
7.2.1. Hospital
7.2.1.1. Market Size Forecast and Y-o-Y Growth
7.2.1.2. Absolute $ Opportunity
7.2.2. Clinics
7.2.2.1. Market Size Forecast and Y-o-Y Growth
Persistence Market Research
7
Global Dermatophytic Onychomycosis Market - Asia Pacific is
projected to expand at the highest CAGR by 2015 - 2021
7.2.2.2. Absolute $ Opportunity
7.2.3. Independent Pharmacy
7.2.3.1. Market Size Forecast and Y-o-Y Growth
7.2.3.2. Absolute $ Opportunity
7.2.4. Mail Order Pharmacies
7.2.4.1. Market Size Forecast and Y-o-Y Growth
7.2.4.2. Absolute $ Opportunity
7.2.5. Drug Stores
7.2.5.1. Market Size Forecast and Y-o-Y Growth
7.2.5.2. Absolute $ Opportunity
7.3. Market Attractiveness Analysis, By Distribution Channels
8. Global Dermatophytic Onychomycosis Therapeutics Market Analysis, By Region
8.1. Introduction
8.1.1. Y-o-Y Growth Projections, By Region
8.1.2. Market Share & Basis Point (BPS) Analysis, By Region
8.2. Market Forecast, By Region
8.2.1. North America Market Forecast
8.2.2. Europe Market Forecast
8.2.3. APAC Market Forecast
8.2.4. Latin America Market Forecast
8.2.5. MEA Market Forecast
8.3. Regional Attractiveness Analysis, By Region
9. North America Market Value Forecast
9.1. Key Trends
9.2. Market Value Forecast, By Country
9.2.1. US Absolute $ Opportunity
9.2.2. Canada Absolute $ Opportunity
9.3. Market Value Forecast, By Product Type
9.3.1. Tablet
9.3.1.1. Rx. Tablet
9.3.1.2. OTC Tablet
9.3.2. Nail Paint
9.3.2.1. Rx. Nail Paint
Persistence Market Research
8
Global Dermatophytic Onychomycosis Market - Asia Pacific is
projected to expand at the highest CAGR by 2015 - 2021
9.3.2.2. OTC Nail Paint
9.4. Market Value Forecast, By Treatment Type
9.4.1. Oral Therapy
9.4.2. Topical Therapy
9.5. Market Value Forecast, By Distribution Channels
9.5.1. Hospital
9.5.2. Clinics
9.5.3. Independent Pharmacy
9.5.4. Mail Order Pharmacies
9.5.5. Drug Stores
9.6. Drivers & Restraints: Impact Analysis
10. Europe Market Value Forecast
10.1. Key Trends
10.2. Market Value Forecast, By Country
10.2.1. Germany Absolute $ Opportunity
10.2.2. Italy Absolute $ Opportunity
10.2.3. France Absolute $ Opportunity
10.2.4. The United Kingdom Absolute $ Opportunity
10.2.5. Spain Absolute $ Opportunity
10.2.6. Russia Absolute $ Opportunity
10.2.7. Rest of Europe Absolute $ Opportunity
10.3. Market Value Forecast, By Product Type
10.3.1. Tablet
10.3.1.1. Rx. Tablet
10.3.1.2. OTC Tablet
10.3.2. Nail Paint
10.3.2.1. Rx. Nail Paint
10.3.2.2. OTC Nail Paint
10.4. Market Value Forecast, By Treatment Type
10.4.1. Oral Therapy
10.4.2. Topical Therapy
10.5. Market Value Forecast, By Distribution Channels
10.5.1. Hospital
10.5.2. Clinics
Persistence Market Research
9
Global Dermatophytic Onychomycosis Market - Asia Pacific is
projected to expand at the highest CAGR by 2015 - 2021
10.5.3. Independent Pharmacy
10.5.4. Mail Order Pharmacies
10.5.5. Drug Stores
10.6. Drivers & Restraints: Impact Analysis
11. APAC Market Value Forecast
11.1. Key Trends
11.2. Market Value Forecast, By Country
11.2.1. Greater China Absolute $ Opportunity
11.2.2. Japan Absolute $ Opportunity
11.2.3. India Absolute $ Opportunity
11.2.4. Rest of APEJ Absolute $ Opportunity
11.3. Market Value Forecast, By Product Type
11.3.1. Tablet
11.3.1.1. Rx. Tablet
11.3.1.2. OTC Tablet
11.3.2. Nail Paint
11.3.2.1. Rx. Nail Paint
11.3.2.2. OTC Nail Paint
11.4. Market Value Forecast, By Treatment Type
11.4.1. Oral Therapy
11.4.2. Topical Therapy
11.5. Market Value Forecast, By Distribution Channels
11.5.1. Hospital
11.5.2. Clinics
11.5.3. Independent Pharmacy
11.5.4. Mail Order Pharmacies
11.5.5. Drug Stores
11.6. Drivers & Restraints: Impact Analysis
12. Latin America Market Value Forecast
12.1. Key Trends
12.2. Market Value Forecast, By Country
12.2.1. Argentina Absolute $ Opportunity
12.2.2. Brazil Absolute $ Opportunity
Persistence Market Research
10
Global Dermatophytic Onychomycosis Market - Asia Pacific is
projected to expand at the highest CAGR by 2015 - 2021
12.2.3. Mexico Absolute $ Opportunity
12.2.4. Rest of Latin America Absolute $ Opportunity
12.3. Market Value Forecast, By Product Type
12.3.1. Tablet
12.3.1.1. Rx. Tablet
12.3.1.2. OTC Tablet
12.3.2. Nail Paint
12.3.2.1. Rx. Nail Paint
12.3.2.2. OTC Nail Paint
12.4. Market Value Forecast, By Treatment Type
12.4.1. Oral Therapy
12.4.2. Topical Therapy
12.5. Market Value Forecast, By Distribution Channels
12.5.1. Hospital
12.5.2. Clinics
12.5.3. Independent Pharmacy
12.5.4. Mail Order Pharmacies
12.5.5. Drug Stores
12.6. Drivers & Restraints: Impact Analysis
13. MEA Market Value Forecast
13.1. Key Trends
13.2. Market Value Forecast, By Country
13.2.1. GCC Absolute $ Opportunity
13.2.2. South Africa Absolute $ Opportunity
13.2.3. Rest of MEA Absolute $ Opportunity
13.3. Market Value Forecast, By Product Type
13.3.1. Tablet
13.3.1.1. Rx. Tablet
13.3.1.2. OTC Tablet
13.3.2. Nail Paint
13.3.2.1. Rx. Nail Paint
13.3.2.2. OTC Nail Paint
13.4. Market Value Forecast, By Treatment Type
13.4.1. Oral Therapy
Persistence Market Research
11
Global Dermatophytic Onychomycosis Market - Asia Pacific is
projected to expand at the highest CAGR by 2015 - 2021
13.4.2. Topical Therapy
13.5. Market Value Forecast, By Distribution Channels
13.5.1. Hospital
13.5.2. Clinics
13.5.3. Independent Pharmacy
13.5.4. Mail Order Pharmacies
13.5.5. Drug Stores
13.6. Drivers & Restraints: Impact Analysis
14. Competition Landscape
14.1. Brand Share Analysis
14.2. Company Profiles
14.2.1. Revenue
14.2.2. Product Types/Brand Offerings
14.2.3. Key developments
14.2.4. SWOT Analysis
14.3. Company Highlights
14.3.1. Valeant Pharmaceuticals International Inc.
14.3.2. Galderma S.A.
14.3.3. Novartis AG
14.3.4. Pfizer Inc.
14.3.5. Moberg Pharma AB
14.3.6. Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
14.3.7. Anacor Pharmaceuticals, Inc.
List of Tables
Table 01: Global Dermatophytic Onychomycosis Therapeutics Market Value Forecast By
Region, 2014–2021 (US$ Mn)
Table 02: North America Dermatophytic Onychomycosis Therapeutics Market Value Forecast
By Product Type, 2014–2021 (US$ Mn)
Table 03: North America Dermatophytic Onychomycosis Therapeutics Market Value Forecast
By Treatment Type, 2014–2021 (US$ Mn)
Table 04: North America Dermatophytic Onychomycosis Therapeutics Market Value Forecast
By Distribution Channels, 2014–2021 (US$ Mn)
Persistence Market Research
12
Global Dermatophytic Onychomycosis Market - Asia Pacific is
projected to expand at the highest CAGR by 2015 - 2021
Table 05: Europe Dermatophytic Onychomycosis Therapeutics Market Value Forecast By
Product Type, 2014–2021 (US$ Mn)
Table 06: Europe Dermatophytic Onychomycosis Therapeutics Market Value Forecast By
Treatment Type, 2014–2021 (US$ Mn)
Table 07: Europe Dermatophytic Onychomycosis Therapeutics Market Value Forecast By
Distribution Channels, 2014–2021 (US$ Mn)
Table 08: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Forecast By
Product Type, 2014–2021 (US$ Mn)
Table 09: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Forecast By
Treatment Type, 2014–2021 (US$ Mn)
Table 10: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Forecast By
Distribution Channels, 2014–2021 (US$ Mn)
Table 11: Latin America Dermatophytic Onychomycosis Therapeutics Market Value Forecast
By Product Type, 2014–2021 (US$ Mn)
Table 12: Latin America Dermatophytic Onychomycosis Therapeutics Market Value Forecast
By Treatment Type, 2014–2021 (US$ Mn)
Table 13: Latin America Dermatophytic Onychomycosis Therapeutics Market Value Forecast
By Distribution Channels, 2014–2021 (US$ Mn)
Table 14: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Value
Forecast By Product Type, 2014–2021 (US$ Mn)
Table 15: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Value
Forecast By Treatment Type, 2014–2021 (US$ Mn)
Table 16: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Value
Forecast By Distribution Channels, 2014–2021 (US$ Mn)
List of Figures
Figure 01: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth
(%), 2014–2021
Figure
02:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
$
Opportunity, 2014–2021
Figure 03: Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth Comparison By
Product Type, 2014–2021
Figure 04: Dermatophytic Onychomycosis Therapeutics Market Value Share & BPS Analysis
By Product Type, 2014 & 2021
Persistence Market Research
13
Global Dermatophytic Onychomycosis Market - Asia Pacific is
projected to expand at the highest CAGR by 2015 - 2021
Figure 05: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth
(%) for Tablet Segment, 2014–2021
Figure
06:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
$
Opportunity for Tablet Segment, 2014–2021
Figure 07: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth
(%) for Rx. Tablet Sub-segment, 2014–2021
Figure
08:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
$
Opportunity for Rx. Tablet Sub-segment, 2014–2021
Figure 09: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth
(%) for OTC Tablet Sub-segment, 2014–2021
Figure
10:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
$
Opportunity for OTC Tablet Sub-segment, 2014–2021
Figure 11: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth
(%) for Nail Paint Segment, 2014–2021
Figure
12:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
$
Opportunity for Nail Paint Segment, 2014–2021
Figure 13: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth
(%) for Rx. Nail Paint Sub-segment, 2014–2021
Figure
14:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
$
Opportunity for Rx. Nail Paint Sub-segment, 2014–2021
Figure 15: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth
(%) for OTC Nail Paint Sub-segment, 2014–2021
Figure
16:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
$
Opportunity for OTC Nail Paint Sub-segment, 2014–2021
Figure 17: Global Dermatophytic Onychomycosis Therapeutics Market Attractiveness
Analysis By Product Type, 2015–2021
Figure 18: Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth Comparison By
Treatment Type, 2015–2021
Figure 19: Dermatophytic Onychomycosis Therapeutics Market Value Share & BPS Analysis
By Treatment Type, 2014 & 2021
Figure 20: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth
(%) for Oral Segment, 2014–2021
Figure
21:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
Opportunity for Oral Segment, 2014–2021
Persistence Market Research
14
$
Global Dermatophytic Onychomycosis Market - Asia Pacific is
projected to expand at the highest CAGR by 2015 - 2021
Figure 22: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth
(%) for Topical Segment, 2014–2021
Figure
23:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
$
Opportunity for Topical Segment, 2014–2021
Figure 24: Global Dermatophytic Onychomycosis Therapeutics Market Attractiveness
Analysis By Treatment Type, 2015–2021
Figure 25: Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth Comparison By
Distribution Channels, 2015–2021
Figure 26: Dermatophytic Onychomycosis Therapeutics Market Value Share & BPS Analysis
By Distribution Channels, 2014 & 2021
Figure 27: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth
(%) for Hospitals, 2014–2021
Figure
28:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
$
Opportunity for Hospitals, 2014–2021
Figure 29: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth
(%) for Clinics, 2014–2021
Figure
30:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
$
Opportunity for Clinics, 2014–2021
Figure 31: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth
(%) for Independent Pharmacies, 2014–2021
Figure
32:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
$
Opportunity for Independent Pharmacies, 2014–2021
Figure 33: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth
(%) for Mail Order Pharmacies, 2014–2021
Figure
34:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
$
Opportunity for Mail Order Pharmacies, 2014–2021
Figure 35: Global Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth
(%) for Drug Stores, 2014–2021
Figure
36:
Global
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
$
Opportunity for Drug Stores, 2014–2021
Figure 37: Global Dermatophytic Onychomycosis Therapeutics Market Attractiveness
Analysis By Distribution Channels, 2015–2021
Figure 38: Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth Comparison By
Region, 2015–2021
Persistence Market Research
15
Global Dermatophytic Onychomycosis Market - Asia Pacific is
projected to expand at the highest CAGR by 2015 - 2021
Figure 39: Global Dermatophytic Onychomycosis Therapeutics Market Value Share & BPS
Analysis By Region, 2014 & 2021
Figure 40: Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by
North America, 2014–2021
Figure 41: Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by
North America, 2014–2021
Figure 42: Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by
Europe, 2014–2021
Figure 43: Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by
Europe, 2014–2021
Figure 44: Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by
Asia Pacific, 2014–2021
Figure 45: Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by
Asia Pacific, 2014–2021
Figure 46: Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by
Latin America, 2014–2021
Figure 47: Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by
Latin America, 2014–2021
Figure 48: Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth (%) by
Middle East and Africa, 2014–2021
Figure 49: Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity by
Middle East and Africa, 2014–2021
Figure 50: Global Dermatophytic Onychomycosis Therapeutics Market Attractiveness
Analysis By Region, 2015–2021
Figure 51: North America Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth
Comparison By Product Type, 2014–2021
Figure 52: North America Dermatophytic Onychomycosis Therapeutics Market Value Share &
BPS Analysis By Product Type, 2014 & 2021
Figure 53: North America Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y
Growth (%) by U.S., 2014–2021
Figure 54: North America Dermatophytic Onychomycosis Therapeutics Market Absolute $
Opportunity by U.S., 2014–2021
Figure 55: North America Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y
Growth (%) by Canada, 2014–2021
Persistence Market Research
16
Global Dermatophytic Onychomycosis Market - Asia Pacific is
projected to expand at the highest CAGR by 2015 - 2021
Figure 56: North America Dermatophytic Onychomycosis Therapeutics Market Absolute $
Opportunity by Canada, 2014–2021
Figure 57: North America Dermatophytic Onychomycosis Therapeutics Market Attractiveness
Analysis By Product Type, 2015–2021
Figure 58: North America Dermatophytic Onychomycosis Therapeutics Market Attractiveness
Analysis By Distribution Channel, 2015–2021
Figure 59: Europe Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth
Comparison By Product Type, 2014–2021
Figure 60: Europe Dermatophytic Onychomycosis Therapeutics Market Value Share & BPS
Analysis By Product Type, 2014 & 2021
Figure 61: Europe Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth
(%) by Germany, 2014–2021
Figure
62:
Europe
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
$
Opportunity by Germany, 2014–2021
Figure 63: Europe Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth
(%) by France, 2014–2021
Figure
64:
Europe
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
$
Opportunity by France, 2014–2021
Figure 65: Europe Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth
(%) by U.K., 2014–2021
Figure
66:
Europe
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
$
Opportunity by U.K., 2014–2021
Figure 67: Europe Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth
(%) by Italy, 2014–2021
Figure
68:
Europe
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
$
Opportunity by Italy, 2014–2021
Figure 69: Europe Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth
(%) by Spain, 2014–2021
Figure
70:
Europe
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
$
Opportunity by Spain, 2014–2021
Figure 71: Europe Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y Growth
(%) by Rest of Europe, 2014–2021
Figure
72:
Europe
Dermatophytic
Onychomycosis
Therapeutics
Market
Absolute
Opportunity by Rest of Europe, 2014–2021
Persistence Market Research
17
$
Global Dermatophytic Onychomycosis Market - Asia Pacific is
projected to expand at the highest CAGR by 2015 - 2021
Figure 73: Europe Dermatophytic Onychomycosis Therapeutics Market Attractiveness
Analysis By Product Type, 2015–2021
Figure 74: Europe Dermatophytic Onychomycosis Therapeutics Market Attractiveness
Analysis By Distribution Channels, 2015–2021
Figure 75: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth
Comparison By Product Type, 2014–2021
Figure 76: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Share &
BPS Analysis By Product Type, 2014 & 2021
Figure 77: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y
Growth (%) by Japan, 2014–2021
Figure 78: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Absolute $
Opportunity by Japan, 2014–2021
Figure 79: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y
Growth (%) by China, 2014–2021
Figure 80: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Absolute $
Opportunity by China, 2014–2021
Figure 81: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y
Growth (%) by India, 2014–2021
Figure 82: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Absolute $
Opportunity by India, 2014–2021
Figure 83: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y
Growth (%) by Australia & New Zealand, 2014–2021
Figure 84: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Absolute $
Opportunity by Australia & New Zealand, 2014–2021
Figure 85: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y
Growth (%) by Rest of Asia Pacific, 2014–2021
Figure 86: Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Absolute $
Opportunity by Rest of Asia Pacific, 2014–2021
Figure 87: APAC Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis
By Product Type, 2015–2021
Figure 88: APAC Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis
By Distribution Channel, 2015–2021
Figure 89: Latin America Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Growth
Comparison By Product Type, 2014–2021
Persistence Market Research
18
Global Dermatophytic Onychomycosis Market - Asia Pacific is
projected to expand at the highest CAGR by 2015 - 2021
Figure 90: Latin America Dermatophytic Onychomycosis Therapeutics Market Value Share &
BPS Analysis By Product Type, 2014 & 2021
Figure 91: Latin America Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y
Growth (%) by Brazil, 2014–2021
Figure 92: Latin America
Dermatophytic Onychomycosis Therapeutics Market Absolute $
Opportunity by Brazil, 2014–2021
Figure 93: Latin America Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y
Growth (%) by Mexico, 2014–2021
Figure 94: Latin America
Dermatophytic Onychomycosis Therapeutics Market Absolute $
Opportunity by Mexico, 2014–2021
Figure 95: Latin America Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y
Growth (%) by Argentina, 2014–2021
Figure 96: Latin America
Dermatophytic Onychomycosis Therapeutics Market Absolute $
Opportunity by Argentina, 2014–2021
Figure 97: Latin America Dermatophytic Onychomycosis Therapeutics Market Value & Y-o-Y
Growth (%) by Rest of Latin America, 2014–2021
Figure 98: Latin America
Dermatophytic Onychomycosis Therapeutics Market Absolute $
Opportunity by Rest of Latin America, 2014–2021
Figure 99: Latin America Dermatophytic Onychomycosis Therapeutics Market Attractiveness
Analysis By Product Type, 2015–2021
Figure
100:
Latin
America
Dermatophytic
Onychomycosis
Therapeutics
Market
Market
Growth
Attractiveness Analysis By Distribution Channel, 2015–2021
Figure
101:
MEA
Dermatophytic
Onychomycosis
Therapeutics
Y-o-Y
Comparison By Product Type, 2014–2021
Figure 102: Middle East Dermatophytic Onychomycosis Therapeutics Market Value Share &
BPS Analysis By Product Type, 2014 & 2021
Figure 103: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Value
& Y-o-Y Growth (%) by GCC, 2014–2021
Figure 104: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market
Absolute $ Opportunity by GCC, 2014–2021
Figure 105: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Value
& Y-o-Y Growth (%) by South Africa, 2014–2021
Figure 106: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market
Absolute $ Opportunity by South Africa, 2014–2021
Persistence Market Research
19
Global Dermatophytic Onychomycosis Market - Asia Pacific is
projected to expand at the highest CAGR by 2015 - 2021
Figure 107: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market Value
& Y-o-Y Growth (%) by Rest of MEA, 2014–2021
Figure 108: Middle East and Africa Dermatophytic Onychomycosis Therapeutics Market
Absolute $ Opportunity by Rest of MEA, 2014–2021
Figure 109: MEA Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis
By Product Type, 2015–2021
Figure 110: MEA Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis
By Distribution Channels, 2015–2021
About Us:
Persistence Market Research (PMR) is a full-service market intelligence firm specializing in
syndicated research, custom research, and consulting services. PMR boasts market research
expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy
and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and
Shipping and Transportation industries. The company draws from its multi-disciplinary
capabilities and high-pedigree team of analysts to share data that precisely corresponds to
clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions.
From ready-to-purchase market research reports to customized research solutions, PMR’s
engagement models are highly flexible without compromising on its deep-seated research
values.
Contact Us:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: +1 800-961-0353
Email: [email protected]
Web: http://www.persistencemarketresearch.com
Persistence Market Research
20